Short-term application of low-dose growth hormone in surgical patients: Effects on nitrogen balance and blood glucose

World Journal of Gastroenterology

Volumn 13, Issue 3, 2007, Pages 452-456

  Zhang, Ming Ming ^a   Wu, Xiao Ting ^a   Zhou, Yong ^a   Qian, Kun ^a   Zheng, Ya Min ^b  

^a SICHUAN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Abdominal surgery; Growth hormone; Hyperglycemia; Nitrogen balance; Nutritional support

Indexed keywords

ADDAMEL; ALBUMIN; AMINO ACID; BICARBONATE; FIBRONECTIN; FRESUBIN; GLUCOSE; GLYCINE; GLYCOPHOS; INSULIN; JINTROPIN; LACTOSE; LIPID EMULSION; LIPOVENOES; MANNITOL; MULTIVITAMIN; NITROGEN; NOVAMIN; PLACEBO; PREALBUMIN; RECOMBINANT GROWTH HORMONE; SOLUVIT; TRANSFERRIN; UNCLASSIFIED DRUG; VITALIPID;

ABDOMINAL SURGERY; ADULT; AGED; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; ELECTROLYTE DISTURBANCE; ENTERIC FEEDING; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; INSULIN TREATMENT; LOW CALORY DIET; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; MALNUTRITION; NASOGASTRIC TUBE; NITROGEN BALANCE; NUTRITIONAL SUPPORT; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SEPSIS; SIDE EFFECT; WORM INFECTION;

EID: 33846577330     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i3.452     Document Type: Article

References (34)

1. Hill GL, Douglas RG, Schroeder D. Metabolic basis for the management of patients undergoing major surgery. World J Surg 1993; 17: 146-153
2. Petersson B, Wernerman J, Waller SO, von der Decken A, Vinnars E. Elective abdominal surgery depresses muscle protein synthesis and increases subjective fatigue: effects lasting more than 30 days. Br J Surg 1990; 77: 796-800
3. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med 1991; 325: 525-532
4. Losada F, Garcia-Luna PP, Gomez-Cia T, Garrido M, Pereira JL, Marin F, Astorga R. Effects of human recombinant growth hormone on donor-site healing in burned adults. World J Surg 2002; 26: 2-8
5. Hammarqvist F, Sandgren A, Andersson K, Essen P, McNurlan MA, Garlick PJ, Wernerman J. Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma. Surgery 2001; 129: 576-586
6. Ziegler TR, Rombeau JL, Young LS, Fong Y, Marano M, Lowry SF, Wilmore DW. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab 1992; 74: 865-873
7. Jensen MB, Kissmeyer-Nielsen P, Laurberg S. Perioperative growth hormone treatment increases nitrogen and fluid balance and results in short-term and long-term conservation of lean tissue mass. Am J Clin Nutr 1998; 68: 840-846
8. Concon JM, Soltess D. Rapid micro Kjeldahl digestion of cereal grains and other biological materials. Anal Biochem 1973; 53: 35-41
9. Byrne TA, Morrissey TB, Gatzen C, Benfell K, Nattakom TV, Scheltinga MR, LeBoff MS, Ziegler TR, Wilmore DW. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg 1993; 218: 400-416; discussion 416-418
10. Vara-Thorbeck R, Guerrero JA, Ruiz-Requena ME, Capitan J, Rodriguez M, Rosell J, Mekinassi K, Maldonado M, Martin R. Effects of growth hormone in patients receiving total parenteral nutrition following major gastrointestinal surgery. Hepa-togastroenterology 1992; 39: 270-272
11. Kolstad O, Jenssen TG, Ingebretsen OC, Vinnars E, Revhaug A. Combination of recombinant human growth hormone and glutamine-enriched total parenteral nutrition to surgical patients: effects on circulating amino acids. Clin Nutr 2001; 20: 503-510
12. Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N. The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 2001; 50: 96-104
13. Norrelund H, Moller N, Nair KS, Christiansen JS, Jorgensen JO. Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab 2001; 86: 3120-3129
14. Carrel AL, Allen DB. Effects of growth hormone on adipose tissue. J Pediatr Endocrinol Metab 2000; 13 (Suppl 2): 1003-1009
15. Kissmeyer-Nielsen P, Jensen MB, Laurberg S. Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg 1999; 229: 298-302
16. Petersen SR, Holaday NJ, Jeevanandam M. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 1994; 36: 726-733
17. Biolo G, Iscra F, Bosutti A, Toigo G, Ciocchi B, Geatti O, Gullo A, Guarnieri G. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. Am J Physiol Endocrinol Metab 2000; 279: E323-E332
18. Vara-Thorbeck R, Guerrero JA, Rosell J, Ruiz-Requena E, Capitan JM. Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function. World J Surg 1993; 17: 530-537; discussion 537-538
19. Chu LW, Lam KS, Tam SC, Hu WJ, Hui SL, Chiu A, Chiu KC, Ng P. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol Metab 2001; 86: 1913-1920
20. Petersen SR, Jeevanandam M, Shahbazian LM, Holaday NJ. Reprioritization. of liver protein synthesis resulting from recombinant human growth hormone supplementation in parenterally fed trauma patients: the effect of growth hormone on the acute-phase response. J Trauma 1997; 42: 987-995; discussion 995-996
21. Muscaritoli M, Conversano L, Cangiano C, Capria S, Laviano A, Arcese W, Rossi Fanelli F. Biochemical indices may not accurately reflect changes in nutritional status after allogeneic bone marrow transplantation. Nutrition 1995; 11: 433-436
22. Phang PT, Aeberhardt LE. Effect of nutritional support on routine nutrition assessment parameters and body composition in intensive care unit patients. Can J Surg 1996; 39: 212-219
23. Jones CH, Newstead CG, Will EJ, Smye SW, Davison AM. Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure. Nephrol Dial Transplant 1997; 12: 1406-1413
24. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792
25. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
26. Valera A, Rodriguez-Gil JE, Yun JS, McGrane MM, Hanson RW, Bosch F. Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/ bovine growth hormone gene. FASEB J 1993; 7: 791-800
27. Ikeda A, Chang KT, Matsumoto Y, Furuhata. Y, Nishihara M, Sasaki F, Takahashi M. Obesity and insulin resistance in human growth hormone transgenic rats. Endocrinology 1998; 139: 3057-3063
28. Ng EH, Rock CS, Lazarus D, Staiano-Coico L, Fischer E, Moldawer LL, Lowry SF. Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma model. J Surg Res 1991; 51: 99-105
29. Wolf RF, Ng B, Weksler B, Burt M, Brennan MF. Effect of growth hormone on tumor and host in an animal model. Ann Surg Oncol 1994; 1: 314-320
30. Akaza H, Matsuki K, Matsushima H, Koiso K, Aso Y. Stimulatory effects of growth hormone on rat bladder carcinogenesis. Cancer 1991; 68: 2418-2421
31. Torosian MH. Growth hormone and prostate cancer growth and metastasis in tumor-bearing animals. J Pediatr Endocrinol 1993; 6: 93-97
32. Bartlett DL, Charland S, Torosian MH. Growth hormone, insulin, and somatostatin therapy of cancer cachexia. Cancer 1994; 73: 1499-1504
33. Maneatis T, Baptista J, Connelly K, Blethen S. Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 2000; 13 (Suppl 2): 1035-1044
34. Tacke J, Bolder U, Herrmann A, Berger G, Jauch KW. Longterm risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone. JPEN J Parenter Enteral Nutr 2000; 24: 140-144.